G. Okawara

发表

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

Wilson Roa, T. Whelan, Y. Ung, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MEDiastinal Irradiation and CArdio-Toxic Effects (MEDICATE): Exploring the Relationship between Cardiac Irradiation and High Sensitivity Troponins.

G. Pond, S. Sagar, D. Leong, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.

T. Newman, J. Rusthoven, W. Evans, 1997, Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC.

Early Occurrence of Angiosarcoma in a Woman With a BRCA2 Gene Variation of Unknown Significance Treated With Breast-Conserving Therapy for Bilateral Ductal Carcinoma: A Case Report.

N. Hodgson, S. Popović, G. Okawara, 2015, Clinical breast cancer.

Management of Unresected Stage III Non-small Cell Lung Cancer: A Systematic Review

Y. Ung, J. Mackay, W. Evans, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.

S. Lippman, F. Khuri, R. Lotan, 2001, Journal of the National Cancer Institute.

Metformin in Combination With Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: The OCOG-ALMERA Randomized Clinical Trial.

G. Pond, P. Ellis, W. Roa, 2021, JAMA oncology.

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.

R. Ginsberg, R. Komaki, T. Pajak, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.

J. Ajani, C. Guha, L. Kachnic, 2017, International journal of radiation oncology, biology, physics.

Combined-Modal i ty Therapy for Esophageal Cancer : High-Dose Versus Standard-Dose Radiat ion Therapy

R. Ginsberg, R. Komaki, T. Pajak, 2002 .

Predicting 2-year survival for radiation regimens in advanced non-small cell lung cancer.

W. Sharieff, J. Wright, G. Okawara, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Management of Unresected Stage Ill Non-Small Cell Lung Cancer: A Clinical Practice Guideline

G. Okawara, 2005 .

A Novel Neoadjuvant Therapy for Operable Locally Invasive Non-Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574).

G. Pond, M. Wierzbicki, T. Tsakiridis, 2017, Clinical lung cancer.

Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.

J. Ajani, J. Donohue, J. Bradley, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.

W. McCaskill-Stevens, S. Lippman, F. Khuri, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non-Small-Cell Lung Cancer.

G. Pond, Y. Ung, T. Tsakiridis, 2016, Clinical lung cancer.

A randomised trial of two information packages distributed to new cancer patients before their initial appointment at a regional cancer centre.

A. Gafni, T. Whelan, A. Willan, 1996, British Journal of Cancer.

Longitudinal Quality-of-Life Analysis of RTOG 94-05 (Int 0123):A Phase III Trial of Definitive Chemoradiotherapy for Esophageal Cancer.

R. Ginsberg, R. Komaki, C. Willett, 2011, Gastrointestinal cancer research : GCR.

Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline.

Y. Ung, J. Mackay, W. Evans, 2004, Lung cancer.

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials

M. Suntharalingam, A. Raben, C. Hallemeier, 2023, JAMA network open.

Late-Breaking Abstracts: ASTRO's 64th Annual Meeting (October 23-26, 2022) Study of vs. Followed by

C. Rudin, N. Lee, N. Riaz, 2022 .

Cross-border referral for early breast cancer: an analysis of radiation fractionation patterns

T. Whelan, M. Kuettel, J. Julian, 2006, Current oncology.

Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials

J. Ajani, G. Yothers, L. Kachnic, 2022, American journal of clinical oncology.

Genome-wide host methylation profiling of anal and cervical carcinoma

S. Eschrich, J. Ajani, D. Shibata, 2021, PloS one.

Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.

Jim A. Julian, Zsolt Gabos, Timothy J. Whelan, 2017, Clinical lung cancer.

Association of Phosphorylated Epidermal Growth Factor Receptor with Survival in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Radiotherapy

T. Whelan, H. Hirte, T. Tsakiridis, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium (Se) supplementation in resected stage I non-small cell lung cancer (NSCLC).

R. Marks, G. Goodman, G. Clamon, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapy.

H. Hirte, P. Ellis, S. Sagar, 2019, Clinica chimica acta; international journal of clinical chemistry.

The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada

G. Pond, T. Tsakiridis, A. Swaminath, 2023, Frontiers in oncology.